Introduction

Subdermal contraceptive implant is used to prevent pregnancy temporarily. Subdermal contraceptive implant involve the transfer of a progestin from polymer capsules placed under the skin. According to Centers for Disease Control, in 2017, more than 40 million women in the U.S. were using at least one method of contraception.

Increasing adoption of newer means of contraception and improved awareness about availability and effectivity of contraceptive are collectively contributing to their higher sales in global Contraceptive Implant market.

There are various products for subdermal contraceptive implant in the clinical pipeline includes uniplant, an implant which releases nomegestrol acetate with a one duration of a year will propel the growth of subdermal contraceptive implant market. In February 2018, DKT International and Shanghai Dahua Pharmaceutical Co., Ltd .entered into an agreement to reduce the price of USD 6.90 per unit in 69 countries.

Growing awareness about family planning and sexual health is the primary factor which is expected to increase the growth of subdermal contraceptive implant market. In addition, various cheaper subdermal contraceptive implants such as Sino-implant (II) is anticipated to drive the growth of the subdermal contraceptive implant market.

Additionally, Contraceptive efficacy up to 7 years of Levonorgestrel Implant for example Norplant will also propel the growth of subdermal contraceptive implant market.

High abortion rate is anticipated to drive the demand for contraceptive indirectly driving the growth of subdermal implants market. Increasing government initiative to promote subdermal contraceptive implant will also support the growth of subdermal contraceptive implant market.

However, According to WHO, Levonorgestrel implant users experience menstrual problems including headache, weight change, anxiety and others is anticipated to hamper the growth of subdermal contraceptive implant market.

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Get FREE Report Sample

Market Segmentation

Product type	Etonogestrel (progesterone-only) progestin levonorgestrel
End-User	Hospital Specialty clinics Ambulatory surgical centers

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

Get a Customized Version

Key Players

The subdermal contraceptive implant market is a highly fragmented market that includes a number of small players. Some of the key Players for subdermal contraceptive implant market include Shanghai Dahua Pharmaceutical Co. Ltd., Reckitt Benckiser Group plc, Allergan plc, Ansell Limited, Karex Industries The Female Health Company, Teva Pharmaceutical Industries, Ltd. Bayer AG and Merck & Co.

Most manufacturers are focused on development of new and innovative products to increase their market share. These companies are also focused towards building a strong distribution network through partnership to increase their geographical presence.